EMEA-002671-PIP02-20
Key facts
| Invented name |
Pelgraz
|
| Active substance |
pegfilgrastim
|
| Therapeutic area |
Haematology-Hemostaseology
|
| Decision number |
P/0206/2021
|
| PIP number |
EMEA-002671-PIP02-20
|
| Pharmaceutical form(s) |
Solution for injection in pre-filled syringe
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Accord Healthcare S.L.U.
E-mail: regulatory_EU@accord-healthcare.com |
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|